Propanc Biopharma (PPCB) Shares Outstanding (2013 - 2026)
Propanc Biopharma (PPCB) reported Shares Outstanding of 1.12 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 608.0% from 158,727 a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Shares Outstanding (2013 - 2026) Analysis & Trends
Dating back to fiscal Q4 2013, Propanc Biopharma's Shares Outstanding record includes 52 quarters.
- Shares Outstanding has a five-year compound annual growth rate of 56.1% (FY2021 to FY2026).
- By fiscal year, Shares Outstanding came in at 158,727 in FY2025 (-95.3%), 3.4 million in FY2024, 69,552 in FY2023 (-97.4%) and 2.65 million in FY2022.
- The fiscal Q4 2026 figure ranks as the highest quarterly Shares Outstanding since fiscal Q1 2025.
- Year over year, Shares Outstanding gained in 1 of the last five quarters, with growth averaging 44.4%.
- The high point for year-over-year Shares Outstanding in five years was fiscal Q4 2026 (growth of 608.0%); the low point was fiscal Q2 2025 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.37 Bn | 1,107.95 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 618.39 Bn | 536.92 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 508.07 Bn | 481.19 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.65 Bn | 262.64 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 236.65 Bn | 192.05 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 192.73 Bn | 166.92 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Propanc Biopharma | 348,349.79 | -1.66 Mn | - | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Dec 31, 2025 | 534,414.00 |
| Sep 30, 2025 | 493,261.00 |
| Jun 30, 2025 | 158,727.00 |
| Mar 31, 2025 | 173,040.00 |
| Dec 31, 2024 | 534.00 |
| Sep 30, 2024 | 23.64 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 2.39 Mn |
| Dec 31, 2023 | 952,537.00 |
| Sep 30, 2023 | 439,587.00 |
| Jun 30, 2023 | 69,552.00 |
| Mar 31, 2023 | 76,963.00 |
| Dec 31, 2022 | 2.65 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.65 Mn |
| Mar 31, 2022 | 2.65 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 121,304.00 |
API Access
Propanc Biopharma Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();